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HIV-1 Nef protein is important for pathogenicity, but its biochemical function remains obscure. To clarify its role, a yeast
two-hybrid system (ths) screening was utilized to identify Nef cellular partners. Of 79 yeast clones harboring cDNAs for
putative Nef binding proteins, 27 (34%) contained the coding region for HsN3 proteasomal subunit. HsN3 behaved as bona
fide Nef partner in ths control crosses. Nef–HsN3 interaction was confirmed by in vitro binding experiments. In particular,
recombinant Nef was able to capture the HsN3 subunit from a natural proteasome preparation. In Nef, the interacting
region was mapped within aa 34–143, which span the structured portion of the protein, including the SH3-binding domain.
In HsN3, Nef-binding portion was restricted to aa 73–249, and the tract 219–249—reminiscent of SH3 domain N-terminal
3/5ths—was shown to be essential, though not sufficient. Attempts to purify a Nef–HsN3 complex from transfected COS7
cells were unsuccessful. However, Nef was found to markedly downregulate intracellular levels of both a coexpressed
HsN3 and the endogenous simian homologue. These results suggest that Nef, by binding to a subunit, might alter proteasome
function in infected cells. q 1997 Academic Press
INTRODUCTION 1 receptor, CD4 downregulation might either impair CD4
signalling, or prevent cell superinfection, or both. Re-
Primate retrovirus nef genes code for a 24- to 34-kDa
cently, Nef has also been shown to trigger endocytosis
protein synthesized abundantly at an early stage of viral
of MHCI molecules (Schwartz et al., 1996). Infectivity en-
replication (Cullen, 1994; Ratner and Niedermann, 1995;
hancement and CD4 downregulation are separable Nef
Trono, 1995; Harris, 1996). Nef is dispensable for replica-
activities, since some mutations abolishing the former —
tion in vitro, but contributes substantially to viral pathoge-
namely, those altering a PxxP repeat domain—leave
nicity in animal models (Kestler III et al., 1991; Jamieson
CD4 downregulation unaffected (Goldsmith et al., 1995;
et al., 1994), with the notable exception of neonatal ma-
Saksela et al., 1995).
caques (Baba et al., 1995). Defects in the nef gene ac-
In addition, Nef expression modulates T-cell activation
count for some of the described cohorts of long-term
events (Skowronski et al., 1993; Baur et al., 1994; Rhee
nonprogressors among HIV-1-infected humans (Deacon
and Marsh, 1994). In some experimental settings it has
et al., 1995). In agreement with in vivo data, in vitro nef
been reported to interfere with the induction of transcrip-
product stimulates viral growth via a direct enhancement
tion factors NF-kB and AP1, which participate in immune,of virion infectivity (Aiken and Trono, 1995; Chowers et
inflammatory, and antiviral responses (Niederman et al.,al., 1995; Miller et al., 1995; Schwartz et al., 1995), which
1992, 1993).seems to involve incorporation of Nef into viral particles
How Nef can produce such an array of disparate ef-and its processing by HIV-1 protease (Pandori et al.,
fects remains elusive in molecular terms. Clues have1996; Welker et al., 1996; Bukovsky et al., 1997). Another
come from studies attempting to identify cellular Nef-well established Nef effect is the downregulation of CD4
binding proteins. Concordant results from Nef–CD4exposure on the cell surface (Garcia and Miller, 1991),
coexpression experiments in insect cells (Harris andinduced by endocytosis enhancement (Aiken et al., 1994).
Neil, 1994) or yeast two-hybrid system (Rossi et al., 1996)In view of CD4’s role both as T cell receptor (TCR) acces-
and from nuclear magnetic resonance studies (Grzesieksory component in healthy T cells, and as the main HIV-
et al., 1996) indicate that Nef binds at low affinity the
cytoplasmic tail of CD4. This suggests that a transient
Nef–CD4 physical interaction might be one of the events1 Present address: A. N. Belozersky Institute of Physico-Chemical
Biology, Moscow State University, 119899 Moscow, Russia. routing CD4 to endosomes. Nef PxxP motifs have been
2 To whom correspondence and reprint requests should be ad-
shown to interact with the SH3 domain of members ofdressed at the Istituto di Genetica Biochimica ed Evoluzionistica, CNR,
the Src tyrosine-protein kinase family, albeit discrepanc-via Abbiategrasso 207, I-27100 Pavia, Italy. Fax: /39-382-422286.
E-mail: milanesi@ipvgbe.igbe.pv.cnr.it. ies exist as to the preference for Hck, Lyn, or Lck (Sak-
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sela et al., 1995; Collette et al., 1996; Greenway et al., induces a selective depletion of intracellular HsN3. Thus,
Nef apparently joins Tax and pX proteins in the list of1996). Since (i) Lck constitutively associates to the cyto-
plasmic domain of CD4, (ii) Lck or related kinases are retroid virus products committed, inter alia, to alter pro-
teasome function.involved in the signal cascades emanating from TCR, and
(iii) Nef SH3 interacting domain is essential for infectivity
enhancement, one could conclude that Lck or related MATERIALS AND METHODS
proteins have the potential for participating in all Nef
Plasmid constructions
activities mentioned above. Serine/threonine protein ki-
nases have also been implicated as Nef partners. Nef HIV-1 (BH10 strain) nef gene, minus the natural ATG,
was amplified from the cloned provirus DNA using Pfuinterferes in transfected cells with protein kinase C theta
isozyme (Smith et al., 1996), the one specifically involved polymerase (Stratagene) and the primer pair 5*-TCG-
CCGGAATTCGGTGGCAAGTGGTCAAAAAGTAGT (up-in T-cell activation. Furthermore, Nef copurifies with, and
activates, some p21-activated kinase (PAK) family mem- stream) and 5*-ACGCCTCTGCAGTCAGCAGTTCTTGAA-
GTACTCCGG3* (downstream). The amplification productbers (Nunn and Marsh, 1996; Sawai et al., 1996; Lu et
al., 1996), and mutations impairing copurification also was digested with EcoRI and PstI (underlined in the prim-
ers) and the 618-bp nef fragment cloned downstreamblock virus pathogenicity in the SIV/rhesus macaque
model (Sawai et al., 1996). Finally, virion incorporation of from, and in frame with, GAL4DB coding region into
pGBT9 vector (Clontech), to create pGBT9-Nef. The samea Ser/Thr kinase needs Nef and might account for HIV-
1 matrix protein phosphorylation (Swingler et al., 1997). nef insert was introduced into pGEX-4T-1 (Pharmacia)
and pTrc-His-B (Invitrogen) Escherichia coli expressionNef can assume different cell localizations and oligo-
merize (reviewed in Ratner and Niederman, 1995 and vectors, generating pGEX-Nef and pTRC-Nef, respec-
tively.Harris, 1996), thus it might contact different proteins in
distinct compartments and function as an adapter linking For pMTNef plasmid construction, the full-length nef
gene (ATG conserved) was amplified from HIV-1 BH10 DNAmany partners at once at a given site. In a search for
additional Nef cellular partners, we exploited the yeast with the primer pair 5*GCTTGGCTGCAGTTTTGCTATAAG-
ATGGGTGGC (upstream) and 5*GTAGAATTCTCGATG-two-hybrid system (ths; Fields and Song, 1989) to directly
isolate genes coding for HIV-1 Nef binding proteins. An TCAGCAGTTCTTGAAG (downstream). The product was cut
with PstI and EcoRI (underlined in the primers) and clonedearlier report adopting this approach identified b-COP
as a Nef interacting protein (Benichou et al., 1994). into the same sites of pMT-2 eukaryotic expression vector
(a generous gift of P. Comoglio). Similarly, to generateIn our screening, the gene for HsN3 proteasomal sub-
unit and for the deubiquitinating protease pDFFRX pMTHA-Nef plasmid nef sequence was amplified with the
primers 5*GCTATAACCCGGGTGGCAAGTGG (upstream)emerged as frequent isolates. The proteasome is the
principal multicatalitic complex responsible for nonlyso- and 5*GCTAAGCTTCAGCAGTTCTTGAAG (downstream)
and cloned into SmaI–HindIII sites of pBSHA plasmid (asomal protein breakdown in eukaryotic cells (Coux et al.,
1996). Misfolded and damaged proteins are targeted to gift of L. Cartegni), downstream from a stretch encoding
influenza Hemagglutinin HA epitope (YPYDVPDYA). Thethe proteasome for degradation. Proteasome is also in-
volved in the generation of peptides for class I MHC. segment encoding HA–Nef fusion was then reexcised as
a PstI–HindIII (blunted) fragment and ligated into the PstI–Finally, proteasome has been implicated in many cellular
regulatory mechanisms that depend on specific proteo- SmaI-linearized pMT-2 vector.
pBS-HsN3 plasmid was created by subcloning intolytic modifications, the regulation of NF-kB and AP1
among them. The 20S proteasome core associates to pBlueScriptSK/ vector the sequence encoding full-
length HsN3 protein, excised as a 940-bp EcoRI–XhoIadditional factors, the principal being the 19S factor,
which generates 26S proteasome and confers ubiquitin fragment from one of the pGAD-GH-HsN3 clones isolated
with THS. Since this cDNA lacks the natural HsN3 ATG,dependence on the proteasomal enzymes. Ubiquitination
at lysine residues, beyond being a degradation signal, the RNA transcript driven by pBS-HsN3 T3 promoter is
assumed to be translated in vitro (see below) as a HsN3is emerging also as an activating signal, e.g., to turn on
the IkB kinase complex which activates NF-kB, and to version with a shortened propeptide, initiated from the
internal ATG12. The identical EcoRI–XhoI fragment wastrigger the endocytosis of surface receptors (reviewed in
Hochstrasser, 1996). In view of the pervasive role played inserted into pGEX-4T-3 vector (Pharmacia), creating
pGEX-HsN3. Finally, pMTHsN3 construct was obtainedby ubiquitination and proteasome activities, targeting by
Nef of two players in these phenomena might partly ex- by amplifying HsN3 coding sequence from pGAD-GH-
HsN3. The 5* primer (5*-GCTTGGCTGCAGAAGATGGAA-plain Nef pleiotropic action in the cell, in particular NF-
kB inhibition. GCGTTTTTGGGGTC) reintroduces natural HsN3 ATG (in
bold face). As the 3* primer, an oligonucleotide matchingNef–HsN3 interaction was confirmed by in vitro bind-
ing assays. Transfection experiments showed that Nef to the pGADGH vector downstream from the polylinker
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(see below) was used. The amplified fragment was cut to probe all the amplified inserts immobilized on nitrocel-
lulose filters, to check the homogeneity of the restrictionwith PstI and SphI endonucleases (the latter one cleaving
once within the amplification product), and the 5* frag- groups. Two to five clones per each recurring insert and
all single clones were rescued into E. coli as describedment was cloned into PstI–KpnI-restricted pMT-2 vector,
along with the SphI– KpnI fragment from pBSHsN3, thus and subjected to standard false positive exclusion tests.
Inserts were sequenced and compared to DNA and pro-reconstituting a complete HsN3 coding sequence.
To obtain Nef and HsN3 deletion derivatives, natural tein data banks by use of the FASTA and BLAST algo-
rithms.restriction sites were exploited to remove portions of the
coding sequences and reinsert the shortened genes into To quantify b-gal reporter activation in yeast double
transformants expressing one of the DB-Nef 1 A-HsN3DpGBT9 or pGAD-GH vectors, respectively.
All the amplified inserts mentioned above have been or DB-NefD 1 A-HsN3 combinations, cell extracts were
assayed in liquid for b-gal (Ausbel et al., 1991) and forfully sequenced prior to use in subsequent experiments.
total protein concentration, and reporter enzyme activity
was calculated.Yeast two-hybrid system
Recombinant proteinsSaccharomyces cerevisiae HF7c strain, carrying HIS3
and lacZ markers under the control of Gal4 binding se-
E. coli DH5-a cells harboring pGEX-Nef or pGEX-HsN3
quences, was transformed with pGBT9-Nef according to
were induced with 1 mM isopropyl-b-D-thiogalctopyrano-
the lithium acetate protocol and selected for leucine pro-
side (IPTG) for 3 hr, and the corresponding glutathione
totrophy on SD-Leu0 plates. Alternatively, yeast cells
S-transferase (Gst)–Nef and Gst–HsN3 hybrid proteins
were double transformed with pGBT9-Nef and either
were purified from cleared bacterial lysates by glutathi-
pGAD424 or pTD1 plasmids, driving the synthesis of
one–Sepharose (Pharmacia) chromatography, according
Gal4-A alone or Gal4-A fused to aa 84–708 of SV40 TAg,
to manufacturer instructions, in the presence of protease
respectively. Cells were selected for leucine and tripto-
inhibitors (10 mg/ml each of leupeptin, pepstatin, aproti-
phan prototrophy on SD plates lacking both amino acids.
nin, and 1 mM phenyl-metyl-sulfonyl fluoride and ben-
Yeast colonies were then subjected to a filter test for
zamidine). GST fusions were either left adsorbed to the
b-galactosidase expression, as described (Rossi et al.,
resin or eluted with 10 mM reduced glutathione in 25
1996). Both pGBT9-Nef single transformants and pGBT9-
mM Tris–HCl, pH 7.5, and dialyzed against PBS.
Nef/pGAD424 and pGBT9-Nef/pTD1 double trans-
Hexahistidine-tagged Nef (His-Nef) synthesis was in-
formants were found to be negative for b-galactosidase
duced in E. coli-DH5-a (pTrc-Nef) cells with 1 mM IPTG,
production, which suggested that Nef fusion could nei-
for 3 hr. The protein was directly extracted from bacterial
ther activate Gal4 responsive reporter alone (mimicking
pellet with buffered 6 M Guanidinium–HCl and subse-
an activation domain) nor bind spuriously Gal4-A or Gal4-
quently purified on Ni-NTA-agarose resin (Qiagen) under
A fusions. A commercial cDNA library from HeLa cells,
denaturing conditions, according to manufacturer in-
cloned into pGAD-GH vector (Clontech) was amplified in
structions. His-Nef was renatured while still bound to the
E. coli, and DNA was purified with a double CsCl gradi-
resin by sequential washes in decreasing urea concen-
ent. The library was overtransformed into yeast harboring
trations, eluted with 300 mM imidazole, and extensively
pGBT9-Nef, and double transformants were plated for
dyalized against PBS-protease inhibitors.
selection on SD medium w/o Trp, Leu, and His, supple-
A L-[35S]methionine-labeled HsN3 protein was synthe-
mented with 10 mM 3-aminotriazole; an aliquot was
sized in vitro by programming the TNT-T3 coupled tran-
plated on SD-Leu0Trp0 to estimate the number of
scription-translation rabbit reticulocyte lysate system
screened double transformants. Colonies grown on triple
(Promega) with pBS-HsN3 plasmid. The radiolabeled
selective medium were counterscreened for b-galactosi-
protein was used unpurified in subsequent assays.
dase expression by the standard filter assay. Positive
20S proteasome particles were purified from HeLa
clones were then analyzed to identify clones sharing a
cells following a published procedure (Rivett et al., 1994).
cDNA insert. Single colonies were picked from plates
and dispersed in 100 ml of sterile distilled water. The Electrophoresis and Western blotting
cDNAs in the library plasmid were amplified by use of
thd primers 5*-CTAGAACTAGTGGATCCCCCGGGC- In experiments exploiting L-[35S]methionine-labeling
(see below), proteins were resolved by SDS–PAGE (12%TGC3* (upstream) and 5*-GCGCGCGTAATACGACTC-
ACTATAGGG3* (downstream), annealing to pGAD-GH polyacrylamide in the resolving gel) and visualized/quan-
tified by use of a phosphorimager (445 SI, Molecularpolylinker on either side of the insert. The PCR products
were then restricted with either HaeIII or HinfI. A repre- Dynamics). In nonradioactive experiments, proteins were
electroblotted onto nitrocellulose membrane. This wassentative from each group of similar restriction patterns
was radiolabeled (MegaPrime kit, Amersham) and used saturated first in 1% bovine casein in 50 mM Tri–HCl,
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pH 7.5, 50 mM NaCl, 0.15% Tween 20 (WB buffer), at ern blot. In a third approach, at 45 hr cells were starved
for 30 min in methionine and serum-free medium androom temperature for 1 hr, and subsequently in the same
buffer containing 5% Skimmilk (Difco) in place of casein, labeled for 2 hr in 3 ml of the same medium containing
200 mCi L-[35S]methionine (Pro-Mix, 1000 Ci/mmol, Am-for another hour. Then it was incubated at room tempera-
ture for 2 hr with appropriate dilutions of one of the fol- ersham). They were then dissolved in 0.5% Nonidet P-
40-lysis buffer and processed as described above. Thelowing antibodies: monoclonal antibody (MAb) 2001 anti
Nef (Chemicon); MAb 12CA5 anti-HA (Boehringer); MAb centrifugation supernatants were immunoprecipitated
with rabbit polyclonal antibody H847 anti-human protea-6630 anti-vimentin (Sigma); MAb MCP205 anti-HsN3,
MAb MCP257 anti-HC9, MAb MCP102 anti-C10 (a gener- some (gift of K. Hendil).
To analyze endogenous N3 gene transcription in theous gift of K. Hendil). After three washes in WB-Skimmilk
buffer, membranes were incubated for 1 hr at room tem- presence of various pMT-2 derivatives, transfectants
were processed for Northern blotting. Cells were lysedperature with horseradish peroxidase (HRP)-conjugated
anti-mouse, and revealed with an HRP chemiluminescent and total RNA purified according to the RNeasy kit (Qia-
gen) specifications. Per each transfectant, 6 mg of puri-substrate (Super Signal, Pierce). Blots were exposed to
X-ray film, and signals within film linear range were quan- fied RNA was electrophoresed in 1.5% denaturing aga-
rose (in 6% formaldehyde, 20 mM sodium phosphate,tified with an imaging densitometer (GS670, Bio-Rad).
pH 7.00), blotted onto Hybond N/ (Amersham) nylon
In vitro binding assays membrane, and hybridized with 32P-labeled HsN3 cDNA
insert (1.5 1 106 cpm/ml hybridization solution). Wash
For pull-down assays, Gst-Nef, Gst-HsN3, or controls,
stringency was kept moderate (21 SSC, 0.05% SDS at
bound to glutathione–Sepharose resin, were incubated
507) to allow simian transcript recognition. The blot was
with prey protein for 1 hr at 47 in binding buffer (25 mM
rehybridized with actin cDNA probe for HsN3 signal nor-
Hepes, pH 7.4, 50 mM NaCl, 2.5 mM CaCl2 , 1 mM MgCl2 , malization. Bands were quantified by use of the Phos-
0.1% Triton, 1% BSA, added with the protease inhibitor
phorimager.
cocktail), and washed four times in the same buffer lack-
ing BSA. Resin-bound complexes were boiled in SDS –
RESULTSPAGE sample buffer and analyzed in Western blot. Alter-
natively, Gst-HsN3 or the unfused Gst control were im-
A yeast two-hybrid system screening (Fields and Song,
mobilized on nitrocellulose filter using a vacuum slot-blot
1989) for cellular proteins that interact with HIV-1 Nef
device. After preliminary saturation in binding buffer, the
was performed. Yeast expressing a fusion protein com-
membrane was incubated with His-Nef in the same
prising the DNA binding (DB) domain of Gal4 transcrip-
buffer, at 47 for 1 hr. Then the membrane was washed
tional activator and Nef (BH10 isolate) was transformed
four times in binding buffer and processed as for Western
with a library of human cDNAs from HeLa cells, fused
blot, using anti-Nef MAb as the primary antibody.
to the sequence encoding the Gal4 activation (A) domain.
Due to the C-terminal position with respect to Gal4-DB,Cell transfection and analysis
fused Nef is no longer myristoylated. The bait fusion was
preliminarily tested to rule out that it could spuriouslyCOS-7 cells were grown in Dulbecco’s MEM Glutamax
(Gibco), 10% fetal bovine serum. In a typical experiment, activate the ths reporters (Fig. 1).
Of 2 1 107 independent transformants, 79 were se-2.5 mg of each pMT-2 plasmid derivative (individually or
in pairs) has been used to transform a 70% confluent 25- lected on the basis of their ability to activate transcription
of both HIS3 (selectable) and lacZ (screenable) reportercm2 flask, using the standard calcium phosphate proce-
dure. Cells were harvested 48 hr after transfection and genes under the control of Gal4 binding sites. Using a
combined PCR/dot-blot hybridization analysis (see Mate-directly lysed in prewarmed (957) SDS–PAGE sample
buffer. Alternatively, after transfection, cells were washed rials and Methods) the clones were divided in classes
of related cDNA inserts. Partial sequences of severaltwice with ice-cold PBS plus the protease inhibitor cock-
tail, scraped with a rubber policeman in the same buffer, inserts from each class were then obtained to confirm
class homogeneity and aligned to DNA and protein se-briefly spun at 47, and resuspended in cold lysis buffer
(20 mM HEPES, pH 7.4, 50 mM NaCl, 2.5 mM MgCl2 , 1 quences in data banks. This analysis showed that 27
clones (34% of positives) contained the cDNA for HsN3mM CaCl2 , protease inhibitors) added with either 0.01 or
0.5% Nonidet P-40. After a 15-min incubation on ice, cell b-type proteasome subunit (Nothwang et al., 1994). All
five sequenced HsN3 clones contained the completesuspension was forced three times through a 24-gauge
syringe needle and centrifuged in a minifuge (13 krpm/15 coding sequence (including the N-terminal propeptide,
with the exception of the N-terminal Met codon), fusedmin, 47). Comparable amounts of pellet and supernatant
fractions were boiled in SDS–PAGE sample buffer, in frame to Gal4-A.
A second recurrent isolate was found to coincide withloaded onto 12% SDS–PAGE gels, and analyzed in West-
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FIG. 1. Summary of yeast THS tests implicating HsN3 proteasome subunit as a Nef partner. HF7c yeast cells were transformed with plasmid
combinations to express the indicated proteins. Cells were plated onto SD synthetic medium-agar plates, lacking the selection amino acids (Trp
and/or Leu for single or double transformants, Trp, Leu, and His to select for Gal4 activity). After 4 days at 307, plates were inspected for colony
growth. Single colonies from single/double selection plates were reinoculated into liquid SD-selection medium and shaken at 307 overnight. Cells
were lysed for soluble protein extraction according to the vortexing-glass beads method. All the above procedures followed Clontech Matchmaker
kit protocols. Total protein was assayed with the BCA reagent (Pierce), and b-gal was assayed after Ausubel et al. (1991). Activity values (average
of at least three colonies from at least two independent transformations) are expressed as percentage of positive control (the activity in cells
harboring the strongly interacting hybrids Gal4-DB/p53 and Gal4-A/SV40 TAg).
the DFFRX gene (Jones et al., 1996), a human homologue experiments (Fig. 2) exploiting recombinant or natural
Nef and HsN3 proteins in various combinations.of Drosophila fat facets gene, encoding a deubiquitinat-
ing hydrolase (Huang et al., 1995). The DFFRX fusion In one pull-down assay, a GST–Nef fusion and either
GST fused to a Nef-unrelated protein or unfused GSTwas also in frame with Gal4-A, but covered only the C-
terminal 1/6th of the gene (codons 2058–2547 in the were compared for their ability to capture an in vitro-
translated, [35S]methionine-labeled HsN3 protein. Theshortest ths clone).
Both Gal4–A/HsN3 (Fig. 1) and Gal4–A/DFFRX (data GST proteins were captured with a Sepharose–glutathi-
one resin, and the amount of copurifying HsN3 was re-not shown) fusions in the original cross with Gal4–DB/
Nef were strong activators of the lacZ reporter (60–70% vealed by fluorography after SDS–PAGE. Results of such
experiments (Fig. 2A) showed that the Nef–GST fusionactivation relative to a standard ths interaction control,
Gal4–DB/p53 1 Gal4–A/TAg). Both HsN3 (Fig. 1) and has an affinity for HsN3 much higher than the controls.
In a reverse approach, a GST–HsN3 fusion or a controlDFFRX (not shown) passed standard tests for false posi-
tive exclusion, showing that neither protein could spuri- GST were incubated with increasing amounts of a bacte-
rially produced Nef, bearing a six histidine tag at its N-ously activate the reporter. Thus, both proteins appear
as bona fide Nef partners in the yeast system. terminus (His-Nef; data not shown). Alternatively, in-
creasing amounts of either GST–HsN3 or GST were in-These results suggested the possibility that Nef could
bind two distinct components of the ubiquitin-protea- cubated with a fixed amount of His-Nef (Fig. 2B). After
adsorption to Sepharose–glutathione, the captured Nefsome pathway. Subsequent work, reported hereafter,
was aimed at a more extensive characterization of Nef was revealed in Western blot with an anti-Nef mono-
clonal antibody. In both cases, the HsN3 fusion, contraryinteraction with the most frequent isolate, HsN3. Nef
binding properties of the pDFFRX protein, whose com- to GST alone, bound Nef very efficiently, in a dose-depen-
dent manner. The same combinations were assayed inplete cDNA sequence has been recently published
(Jones et al., 1996), are presently under scrutiny. a far-Western format (Fig. 2C), in which increasing
amounts of either GST–HsN3 or GST were immobilizedNef/HsN3 interaction was confirmed by in vitro binding
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FIG. 2. Recombinant Nef binds both recombinant and natural HsN3 subunit in vitro. The indicated Gst fusions, adsorbed to glutathione–Sepharose
resin, were incubated with in vitro translated HsN3 (A), bacterially expressed, purified His-Nef (B), or a purified human proteasome preparation (D,
E), and analyzed, as described under Materials and Methods. Gst-UP: Gst-fused, Nef-unrelated protein (hepatitis B virus L surface protein, PreS
domain). In C, Gst-HsN3 or the unfused Gst control dotted on nitrocellulose were serially incubated with His-Nef, anti-Nef MAb, and HRP-anti-
mouse antibody.
onto a nitrocellulose membrane and incubated with His- proteasome preparation, or, alternatively, that it could
bind HsN3 still incorporated into 20S particles, whichtagged Nef. Also in this case, HsN3 fusion, but not GST,
retained Nef, and did it in proportion to the quantity of were consequently dissociated.
In order to define the interacting regions in Nef andimmobilized protein.
To ascertain the ability of Nef to interact with natural HsN3, a series of directional deletion mutants were cre-
ated for both proteins, and each mutant was then testedHsN3, the assay utilizing Gst–Nef fusion as the bait was
repeated using as the prey a purified proteasome prepa- against the intact partner in ths. Nef deletion variants
fused to Gal4–DB were coexpressed in yeast with Gal4–ration instead of an in vitro-translated HsN3 subunit.
Pulled-down proteins were detected in Western blot with A/HsN3, and the extent of reporter gene activation was
measured with a liquid b-gal assay. As shown in Fig. 3,either an anti-HsN3 monoclonal antibody or a rabbit anti-
human proteasome antiserum (which apparently in- deletion analysis allowed restriction of the HsN3-inter-
acting portion to Nef amino acids 34–143.cluded negligible amounts of anti-HsN3 specific antibod-
ies). In agreement with previous results, GST–Nef, but Conversely, a set of HsN3 deletion mutants fused to
Gal4-A was expressed in yeast cells together with DB-not unfused GST, captured the mature HsN3 subunit
present in purified proteasomes, as shown by the spe- Nef. Results from these experiments (Fig. 4) localized the
Nef-binding region between HsN3 amino acids 73–249.cific monoclonal (Figs. 2D and 2E). By contrast, the anti-
serum revealed trace amounts of the total proteasome A C-terminal stretch (aa 219–249) appeared particularly
important, since its removal abolished Nef interaction.subunit ladder with either GST or GST–Nef bait (Fig.
2E). The opposite results obtained with the HsN3-specific However, this C-terminal region alone was not sufficient
for Nef-binding.antibody and the antibodies against total proteasome
suggest that the fused Nef moiety could specifically bind To verify that Nef and HsN3 interact also in intact
mammalian cells, COS7 cells were transiently trans-HsN3 among spontaneously dissociated subunits in the
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FIG. 3. Deletional mapping of the Nef portion which binds HsN3. Nef or Nef deletions were expressed in the yeast system as Gal4-DB fusions
(top), in combination with Gal4-A-HsN3, as originally cloned in ths. Over the diagrammatic representation of wt Nef, the position of some relevant
sequence tracts (Ratner and Niederman, 1995) is signalled. Selectable (HIS3) or screenable (lacZ) reporter activation was assessed as described
under Materials and Methods and in the legend to Fig. 1 (bottom). The in liquid b-gal activity is reported as percentage of the intact partners cross
(Gal4-DB/Nef X Gal4-A/HsN3).
fected either singly or doubly with plasmid-based expres- that cells singly transfected with the appropriate plasmid
produced the corresponding protein in easily detectablesion vectors for Nef and HsN3, the former either unfused
or carrying an epitope tag from influenza Hemagglutinin amounts (Fig. 5A). Since COS7 cells constitutively ex-
press the simian homologue of HsN3, a baseline amountfused at the N-terminus (designated HA-Nef).
Preliminary immunoblot analysis with monoclonal anti- of simian subunit, electrophoretically indistinguishable
from its human counterpart, was detected in controls thatbodies to Nef (N-terminal epitope), HA or HsN3 revealed
FIG. 4. Delineation of the HsN3 portion which binds Nef. HsN3, as originally cloned in ths or HsN3 deletions were expressed in the yeast system
as Gal4-A fusions (top), in combination with Gal4-DB-Nef, and HIS3 and lacZ reporter activation was assayed (bottom).
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FIG. 5. Nef-induced downregulation of endogenous and transfected N3 subunits in COS-7 cells. Cells transfected to express the indicated
products were analyzed in Western blot (A, B, D), in radioimmunoprecipitation (C), or in Northern blot (E), as described under Materials and Methods.
In A and D, whole cell lysates, probed with distinct antibodies, were analyzed. In B, pellet (P) and supernatant (S) of fractionated cells, analyzed
with anti-HsN3 MAb, are shown. In C, the soluble extract from a replica of transfectants in B-right was analyzed by immunoprecipitation with rabbit
anti-human proteasome serum. In E, total RNA extracted from the same transfectants in C was analyzed in Northern blot using HsN3 cDNA as the
probe and subsequently rehybridized with b-actin probe (a residue of HsN3 signal is still visible below the actin signal in the lower panel). In A–
C, N3 indicates the position of human HsN3 and/or simian HsN3 homolog, which comigrate. In D and E, HA-UP indicates transfectants in which
vector drives the synthesis of a HA-tagged, Nef-unrelated protein (a human HOX family protein).
received the empty vector (pMT-2). Comparison between we then performed immunoprecipitation experiments
from cotransfected cells. Lysates in 0.5% nonionic deter-pMT-2 transfected cells and HsN3 transfectants showed
that the natural simian subunit was present mainly in gent from cells doubly expressing HsN3 and Nef or HA-
Nef were immunoprecipitated with monoclonal antibod-the processed 28-kDa form, typical of the assembled
proteasome, and in lesser amounts in the 32-kDa form ies against Nef, HA epitope, or HsN3, and immunoprecip-
itates were examined by immunoblot with anti-HsN3 orstill bearing the N-terminal propeptide (Thomson and Riv-
ett, 1996). By contrast, in HsN3 transfectants the 32-kDa anti-Nef. While each antibody captured the correspond-
ing antigen, this analysis failed to reveal appreciableform was predominant, arguably because the proportion
synthesized in excess relative to the other subunits could amounts of coprecipitating partner (data not shown).
Nef–HsN3 interaction in cotransfected cells mightnot be incorporated into 20S particles and processed
consequently. (However, that human N3 subunit was have escaped our analysis because it was transient or
was disrupted by the lysis procedure. We then lookedpartly coassembled with other simian subunits was
proven by radioimmunoprecipitation experiments using for an indirect proof of Nef–HsN3 interaction, by verifying
whether Nef coexpression altered the subcellular distri-anti-HsN3 MAb, in which a ladder of coprecipitating en-
dogenous proteasome subunits was revealed along with bution and/or the extent of conversion of precursor to
mature HsN3. A relative increase in HsN3 proproteinHsN3; data not shown.) The unprocessed and processed
forms were separated when cells were subjected to a could be expected if Nef interfered with HsN3 incorpora-
tion into proteasome. To our surprise, immunoblot analy-mild fractionation protocol (0.01% nonionic detergent in
the extraction buffer). While the processed, proteasome- sis demonstrated that Nef induced, on the contrary, a
dramatic downregulation of HsN3 levels. This effect wasassociated form was found principally in the soluble frac-
tion, the precursor form remained in the particulate frac- observed both for the overexpressed human subunit, in
Nef / HsN3 (Fig. 5B) and HA-Nef / HsN3 (not shown)tion (see Fig. 5B). Under similar conditions, both Nef and
HA-Nef were found in the particulate fraction (data not double transformants, and for the endogenous simian
subunit (N3), in Nef (Fig. 5B) and HA-Nef (Fig. 5C) singleshown). On the other hand, when harsher extraction con-
ditions were adopted (0.5% nonionic detergent), Nef and transformants. This implies in particular that the effect
was not discriminating between human and simian N3.both HsN3 forms were largely solubilized (data not
shown). Also, the effect was selective to HsN3 b subunit or its
simian homolog, since the levels of other proteasomalIn an attempt to detect a stable Nef–HsN3 interaction,
AID VY 8752 / 6a48$$$$83 09-18-97 14:01:46 viras AP: VY
41NEF AND PROTEASOME SUBUNIT HsN3
proteins, as visualized in immunoprecipitation with anti- by the finding, reported here, that HIV-1 Nef protein can
bind proteasomal subunit HsN3 and determine its selec-proteasome antiserum, were unaffected by Nef in both
Nef single transfectants (data not shown) and Nef plus tive downmodulation.
20S proteasome (Coux et al., 1996) is formed by fourHsN3 double transfectants (Fig. 5D). In the last experi-
ment, we could observe an interpretable HsN3 signal heptameric rings stacked to form a hollow cylinder.
Seven a subunits form each of the outer rings, and sevenonly with a long (2 hr) radioactive pulse. The reduction of
plasmid-driven HsN3 in the presence of Nef was already b subunits form each of the inner rings. The b sub-
units—which include the proteolytically active ones—appreciable at the 0-hr chase point (Fig. 5D) and did
not change appreciably through a 12-hr chase (data not are coded for by 7 related genes in yeast and by more
than 10 genes in mammalians. They are synthesized asshown). Thus, to the best of our knowledge, HsN3 down-
regulation is either a translational or an early posttransla- inactive proproteins, carrying an N-terminal propeptide
that chaperones them into the assembling 20S complextional effect.
In mammals, three proteasomal subunits, LMP2, (Chen and Hochstrasser, 1996; Schmidtke et al., 1996)
and is removed upon the sealing of the catalytic cham-LMP7, and MECL-1, are inducible by g-interferon and
replace other constitutive subunits (LMP2 and LMP7 are ber, thus preventing the premature activation of the prote-
ases. HsN3 is a constitutive proteasome b subunit (Koppimportant for class I T antigens presentation). Protea-
some subunits are modulated at the transcriptional level et al., 1995), but is thought to be proteolytically inactive
(Schmidtke et al., 1996).also in other settings, for instance during insect develop-
ment, in mitogen-stimulated cells, and in muscle atrophy In our study, HsN3 was isolated as the most frequent
Nef partner in a ths screening covering 2 1 106 indepen-in mammalians (reviewed in Coux et al., 1996). In addi-
tion, Nef has been known to influence transcription of a dent clones. Next, the interaction was confirmed by in
vitro experiments, indicating that Nef could bind freenumber of genes. Thus, proteasome subunit genes can
undergo transcriptional modulation, and Nef might in HsN3, not only in recombinant versions but also as the
mature protein dissociated from a proteasome prepara-principle induce it. To ascertain whether Nef was turning
off transcription from the HsN3 promoter on the vector tion either spontaneously or after Nef binding.
In Nef, the region essential for interaction was mappedand/or from the endogenous simian gene promoter, Nef
or HA-Nef transformants and Nef/HA-Nef plus HsN3 dou- to aa 34–143. This tract covers almost completely the
most extended structured portion in a Nef crystal model,ble transformants were analyzed in Northern blot for their
content in HsN3 mRNA. No appreciable Nef-dependent aa 71–148, including, from the N-terminus, PPII helix, a
helixes A and B, and b-sheets A–C, up to the boundarydecrease in HsN3 or natural simian homolog mRNAs
was revealed by this analysis in repeated experiments. of the solvent-exposed loop 149–177 (Lee et al., 1996).
Tract 34–143 includes the Arg105–Arg106 motif essen-A recapitulative experiment is shown in Figs. 5D and 5E,
where equal amounts of either total protein or total RNA tial for copurification with, and activation of, PAKs by Nef
(Sawai et al., 1996; Lu et al., 1996), as well as all thefrom COS-7 cells expressing the empty vector, a HA-
tagged, Nef-unrelated protein, or HA-Nef were compared residues involved in tyrosine kinase SH3 binding (Lee et
al., 1996), with the exception of the conserved Pro147,for content in simian proteasome subunits N3, C10 (an-
other b-type subunit), and C9 (an a-type subunit) (Fig. which enhances SH3 binding in vitro (Saksela et al.,
1995). More generally, deletion/domain-swapping stud-5D) and N3 transcript content (Fig. 5E), in Western blot
and Northern blot, respectively. While the level of N3 ies have shown that the integrity of this central portion
of the protein is important for Nef activity in the principalprotein in HA-Nef transfectants was approximately 1/15th
relative to controls, the level of N3 mRNA was apparently assays, Nef-induced CD4 downregulation (Goldsmith et
al., 1995; Garcia and Foster, 1996), infectivity enhance-unaffected by HA-Nef expression, and the levels of dis-
tinct proteasome subunits C9 and C10 appeared un- ment (Goldsmith et al., 1995), and PAK copurification
(Garcia and Foster, 1996). Truncation at position 134, onchanged as well.
the other hand, deletes the loop charged residues found
to be important for CD4 downregulation (Aiken et al.,DISCUSSION
1996).
The interacting HsN3 region could be restricted to re-A number of virus proteins are tailored to accomplish
multiple tasks, in agreement with viruses’ commitment gion 73–249, with aa 219–249 being essential, though
not sufficient. It is worth noting that the C-terminal portionto genetic economy. Lentiviral Nef proteins warrant a
special mention in this context, since the list of events of proteasome b-type subunits is, together with the N-
terminal propeptide, the least conserved and a probablethey can trigger in infected cells is steadily growing, and
at least the two best documented ones, CD4 receptor mediator of subunit-specific functions (Coux et al., 1996).
More interestingly, HsN3 C-terminal aa 219–264 can bedownregulation and virion infectivity enhancement, seem
to reflect separable activities. The list is further extended aligned to SH3 domains from Src-related tyrosine kinases
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FIG. 6. HsN3 C-terminus is homologous to the SH3 protein module. HsN3 sequence was compared with SwissPir data bank, using the BlastP
algorithm. A significant alignment was found between HsN3 C-terminus and Src SH3 domain. HsN3 C-terminal 47 amino acids were then aligned
to a choice of SH3 domains from different proteins, by use of the Clustal algorithm. The amino acid residues involved in PxxP motifs binding by
SH3s (Mayer and Eck, 1995) and (hypothetically) HsN3 have been boxed. The Ile residue in Hck and Lyn sequence important for Nef PxxP repeat
binding (according to in vitro experiments, Saksela et al., 1995; and structural studies, Grzesiek et al., 1996; Lee et al., 1996), and the Phe residue
similarly positioned in HsN3, are underlined.
and other proteins (Fig. 6). SH3 domains are approxi- dispensable for Nef binding, the proteasome subunit
might use for recognition only the N-terminal 3/5 of themately 60 aa long and fold into five b-sheets interrupted
by loops. Crystallographic and mutational analysis have SH3-like stretch. The fact that sequences in the upstream
73–217 tract are also required for Nef binding mightshown that seven aromatic, hydrophobic, or charged resi-
dues with conserved location and spacing in the aligned mean that they either participate in binding or expose in
the optimal conformation the crucial 219–249 tract. ASH3s (highlighted in Fig. 6) are crucial for PxxP repeat
recognition (Mayer and Eck, 1995). HsN3 sequence is more extensive mutational analysis of both partners is
required to substantiate this hypothesis.homologous to SH3 b-sheets 1–4, with the first five criti-
cal residues identical or homologous to at least one In order to demonstrate that Nef–HsN3 interaction can
actually take place inside mammalian cells, nef andknown SH3. Also, a conservative substitution (Phe232)
aligns to the Ile residue in Hck and Lyn SH3 RT loop (Fig. HsN3-coding genes were transfected into COS7 cells.
While attempts to copurify Nef–HsN3 complex were fruit-6) found to give an essential contribution to the interaction
with Nef PxxP (Saksela et al., 1995; Grzesiek et al., 1996; less, a dramatic downregulation of intracellular HsN3
protein levels was observed in Nef transfectants, in faceLee et al., 1996). Thus, Nef binding might be mediated
by recognition of Nef proline-rich motifs by a HsN3 stretch of maintained HsN3 mRNA levels. Nef-induced down-
modulation appeared to affect HsN3 in both the propro-resembling an incomplete SH3 domain. Since our trunca-
tion analysis has indicated that the last 15 HsN3 aa are tein and the mature form.
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Our favored interpretation of the above observations pends on proteolysis by the proteasome (Palombella et
al., 1994). It is tempting to speculate that HsN3 mightis that also within the cell HIV-1 Nef interacts with HsN3
proteasomal subunit, possibly prior to its processing in- play a dedicated role in NF-kB activation, and that Nef-
induced downregulation of HsN3 might in turn be relatedside mature proteasomes. Since Nef binding does not
require per se the N-terminal propeptide, Nef preference to Nef negative effect on NF-kB, reported by some groups
(Niederman et al., 1992, 1993). More generally, by bindingfor HsN3 proprotein might descend from a common sub-
cellular localization and/or the masking in the 20S parti- to a proteasome component, Nef, as well as Tax and
pX, might interfere in a complex way with degradativecle of HsN3 tracts essential for the interaction (see Groll
et al., 1997, for yeast proteasome structure). Nef binding processes, enhancing or depressing the half-life of tran-
scription factors, of other regulatory proteins or of periph-would divert HsN3 to a breakdown pathway. Alterna-
tively, it might induce a negative feedback at a posttran- eral receptors. This could explain in part their markedly
pleiotropic effects in the cell.scriptional stage in HsN3 expression. HsN3 downregula-
tion might imply the replacement by a distinct b-type Another intriguing possibility is that Nef, by interfering
with proteasome function, may depress the presentationsubunit into assembled 20S particles, although this has
not yet been experimentally proven. Admittedly, this of viral T cell antigens by class I MHC, to the advantage
of viral infection establishment or persistence. Such anmodel is speculative in nature, since the essential point
of a Nef–HsN3 physical interaction in intact cells could effect might synergize with MHCI surface downregula-
tion.not be demonstrated, and the downregulation effect
might be indirect. Even in this case one must admit that
the effect is HsN3-specific. ACKNOWLEDGMENTS
The HsN3 downregulation effect is produced with
The authors are grateful to K. Hendil for supplying the anti-protea-
equal efficiency by wild-type, myristoylated Nef and by a some antibodies and for helpful suggestions. This work was supported
N-terminally tagged, nonmyristoylated Nef mutant. This in part by the Istituto Superiore di Sanita`, Progetto di ricerche sull’AIDS,
grant No. 9204-85. F. Rossi was the recipient of a fellowship fromis a striking point, since the other most extensively ana-
the Istituto Superiore di Sanita` (Borse AIDS Italia). A. Evstafieva waslyzed Nef effects are abolished or strongly attenuated by
supported by an EMBO short term postdoctoral fellowship for east-mutational suppression of N-terminal myristoylation. This
european molecular biologists.
may be an indication that HsN3 downregulation reflects
indeed a distinct Nef activity, not related to, e.g., a mem-
REFERENCESbrane targeting dependent activation of a peripheral sig-
nal cascade. On the other hand, it could unveil a function Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E., and Trono, D. (1994).
Nef induces CD4 endocytosis: Requirement for a critical dileucineof a naturally soluble Nef form: the proportion of myristoy-
motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76,lated Nef which is cytosolic in cell fractionation assays;
853–864.
the variant initiated at nef 5*-most internal ATG (Kamin- Aiken, C., and Trono, D. (1995). Nef stimulates human immunodefi-
chik et al., 1991); or the proteolytic Nef fragment (lacking ciency virus type 1 proviral DNA synthesis. J. Virol. 69, 5048–5056.
Aiken, C., Krause, L., Chen, Y., and Trono, D. (1996). Mutational analysisthe N-terminal 1–57 tract) generated by HIV-1 protease
of HIV-1 Nef: Identification of two mutants that are temperature-inside HIV-1 virions (Pandori et al., 1996; Welker et al.,
sensitive for CD4 downregulation. Virology 217, 293–300.1996; Bukovsky et al., 1997), which might exert its effects
Ausbel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G.,
after introduction into the recipient cells. Smith, J. A., and Struhl, K. ed.s (1991). Current protocols in molecular
Targeting of a proteasome subunit, and HsN3 in partic- biology. John Wiley & Sons, New York.
Baba, T. W., Jeong, Y. S., Pennick, D., Bronson, R., Greene, M. F., andular, by viral proteins is not unprecedented. Human T-
Ruprecht, R. M. (1995). Pathogenicity of live, attenuated SIV aftercell leukemia virus type 1 Tax protein has been reported
mucosal infection of neonatal macaques. Science 267, 1820–1825.to bind both HsN3 and the a-type subunit HC9 (Rousset
Baur, A. S., Sawai, E. T., Dazin, P., Fantl, W. J., Cheng-Mayer, C., and
et al., 1996). Hepatitis B virus pX protein binds XAPC7, Peterlin, B. M. (1994). HIV-1 nef leads to inhibition or activation of T
a novel a-type subunit (Fischer et al., 1995; Huang et al., cells depending on its intracellular localization. Immunity 1, 373–
384.1996). Interestingly, the pX region that mediates XAPC7
Benichou, S., Bomsel, M., Bodeus, M., Durand, H., Doute´, M., Letour-binding shows homologies to a Nef helical stretch after
neur, F., Camonis, J., and Benarous, R. (1994). Physical interactionaa 100 (Samuel et al., 1991). Functional parallelism be-
of the HIV-1 Nef protein with b-COP, a component of non-clathrin-
tween Nef, Tax, and pX goes further, because also Tax coated vesicles essential for membrane traffic. J. Biol. Chem. 269,
(Lillehoj and Alexander, 1992) and pX (Wu et al., 1990) 30073–30076.
Bukovsky, A. A., Dorfaman, T., Weiman, A., and Go¨ttlinger, H. G. (1997).have been detected as virion constituents, and like Nef
Nef association with human immunodeficiency virus type 1 virionsmight influence virion infectivity. Both Tax and pX affect
and cleavage by the viral protease. J. Virol. 71, 1013–1018.intracellular signalling, and stimulate in particular NF-kB
Chen, P., and Hochstrasser, M. (1996). Autocatalytic subunit processing
responsive transcription. For both, proteasome subunit couples active site formation in the 20S proteasome to completion
binding has been hypothesized to trigger NF-kB activa- of assembly. Cell 86, 961–972.
Chowers, M. Y., Pandori, M. W., Spina, C. A., Richman, D. D., and Gua-tion (Rousset et al., 1996; Huang et al., 1996), which de-
AID VY 8752 / 6a48$$$$83 09-18-97 14:01:46 viras AP: VY
44 ROSSI ET AL.
telli, J. C. (1995). The growth advantage conferred by HIV-1 nef is A. (1991). Genetic characterization of human immunodeficiency virus
type 1 nef gene products translated in vitro and expressed in mam-determined at the level of viral DNA formation and is independent
of CD4 downregulation. Virology 212, 451–457. malian cells. J. Virol. 65, 583–588.
Kestler III, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K.,Collette, Y., Dutartre, H., Benziane, A., Ramos-Morales, F., Benarous,
R., Harris, M., and Olive, D. (1996). Physical and functional interaction Daniel, M. D., and Desrosiers, R. C. (1991). Importance of the nef
gene for maintenance of high virus loads and for development ofof Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J. Biol.
Chem. 271, 6333–6341. AIDS. Cell 65, 651–662.
Kopp, F., Kristensen, P., Hendil, K. B., Johnsen, A., Sobek, A., and Dahl-Coux, O., Tanaka, K., and Goldberg, A. L. (1996). Structure and functions
of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801–847. mann, B. (1995). The human proteasome subunit HsN3 is located in
the inner rings of the complex dimer. J. Mol. Biol. 248, 264–272.Cullen, B. R. (1994). The role of Nef in the replication cycle of the human
and simian immunodeficiency virus. Virology 205, 1–6. Lee, C., Saksela, K., Mirza, U. A., Chait, B. T., and Kuriyan, J. (1996).
Crystal structure of the conserved core of HIV-1 Nef complexed withDeacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M.,
Hooker, D. J., McPhee, D. A., Greenway, A. L., Ellett, A., Chatfield, C., a Src family SH3 domain. Cell 85, 931–942.
Lillehoj, E. P., and Alexander, S. S., Jr. (1992). Virion-associated trans-Lawson, V. A., Crowe, S., Maerz, A., Sonza, S., Learmont, J., Sullivan,
J. S., Cunningham, A., Dwyer, D., Dowton, D., and Mills, J. (1995). regulatory protein of human T-cell leukemia virus type 1. AIDS Res.
Hum. Retroviruses 8, 237–244.Genomic structure of an attenuated quasi species of HIV-1 from
blood transfusion donor and recipients. Science 270, 988–991. Lu, X., Wu, X., Plemenitas, A., Yu, H., Sawai, E. T., Abo, A., and Peterlin,
B. M. (1996). CDC42 and Rac1 are implicated in the activation of theFields, S., and Song, O. (1989). A novel genetic system to detect protein-
protein interactions. Nature 340, 245–246. Nef-associated kinase and replication of HIV-1. Curr. Biol. 6, 1677–
1684.Fischer, M., Runkel, L., and Schaller, H. (1995). HBx protein of hepatitis
B virus interacts with the C-terminal portion of a novel human protea- Mayer, B. J., and Eck, M. J. (1995). Minding your p’s and q’s. Curr. Biol.
5, 364–367.some alpha-subunit. Virus Genes 10, 99–102.
Garcia, J. V., and Miller, D. (1991). Serine phosphorylation-independent Miller, M. D., Warmerdam, M. T., Page, K. A., Feinberg, M. B., and
Greene, W. C. (1995). Expression of the human immunodeficiencydownregulation of cell-surface CD4 by nef. Nature 350, 508–511.
Goldsmith, M. A., Warmerdam, M. T., Atchison, R. E., Miller, M. D., and virus type 1 (HIV-1) nef gene during HIV-1 production increases prog-
eny particle infectivity independently of gp160 or viral entry. J. Virol.Greene, P. C. (1995). Dissociation of the CD4 downregulation and
viral infectivity enhancement functions of human immunodeficiency 69, 579–584.
Niederman, T. H., Garcia, J. V., Hastings, W. R., Luria, S., and Ratner, L.virus type 1 Nef. J. Virol. 69, 4112–4121.
Greenway, A., Azad, A., Mills, J., and McPhee, D. (1996). Human immu- (1992). Human immunodeficiency virus type 1 Nef protein inhibits
NF-kB induction in human T cells. J. Virol. 66, 6213–6219.nodeficiency virus type 1 Nef binds directly to Lck and mitogen-
activated protein kinase, inhibiting kinase activity. J. Virol. 70, 6701– Niederman, T. H., Hastings, W. R., Luria, S., Bandres, J. C., and Ratner,
L. (1993). HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-6708.
Groll, M., Ditzel, L., Lowe, J., Stock, D., Bochtler, M., Bartunik, H. D., and binding activity in human T-cells. Virology 194, 338–344.
Nothwang, H. G., Tamura, T., Tanaka, K., and Ichihara, A. (1994). Se-Huber, R. (1997). Structure of 20S proteasome from yeast at 2.4 A
resolution. Nature 386, 463– 471. quence analyses and inter-species comparisons of the novel human
proteasomal subunits, HsN3, HsC7-I and HsC10-II, confine potentialGrzesiek, S., Bax, A., Clore, G. M., Gronenborn, A. M., Hu, J., Kaufman,
J., Palmer, I., Stahl, S. J., and Wingfield, P. T. (1996). The solution proteolytic active-site residues. Bioch. Biophys. Acta 1219, 361–368.
Nunn, M. F., and Marsh, J. W. (1996). Human immunodeficiency virusstructure of HIV-1 Nef reveals an unexpected fold and permits delin-
eation of the binding surface for the SH3 domain of Hck tyrosine type 1 Nef associates with a member of the p21-activated kinase
family. J. Virol. 70, 6157–6161.protein kinase. Nat. Struct. Biol. 3, 340–344.
Grzesiek, S., Stahl, S. J., Wingfield, P. T., and Bax, A. (1996). The CD4 Palombella, V. J., Rando, O. J., Goldberg, A. L., and Maniatis, T. (1994).
The ubiquitin-proteasome pathway is required for processing thedeterminant for downregulation by HIV-1 Nef directly binds to Nef.
Mapping of the Nef binding surface by NMR. Biochemistry 35, NF-kB1 precursor protein and the activation of NF-kB. Cell 78, 773–
785.10256–10261.
Harris, M. (1996). From negative factor to a critical role in virus patho- Pandori, M. W., Fitch, N. J. S., Craig, H. M., Richman, D. D., Spina, C. A.,
and Guatelli, J. C. (1996). Producer-cell modification of human immu-genesis: the changing fortunes of Nef. J. Gen. Virol. 77, 2379–2392.
Harris, M. P. G., and Neil, J. C. (1994). Myristylation-dependent binding nodeficiency virus type 1: Nef is a virion protein. J. Virol. 70, 4283–
4290.of HIV-1 Nef to CD4. J. Mol. Biol. 241, 136–142.
Hochstrasser, M. (1996). Protein degradation or regulation: Ub the Ratner, L., and Niederman, T. M. J. (1995). Nef. Curr. Top. Microbiol.
Immun. 193, 169–208.judge. Cell 84, 813–815.
Huang, Y., Baker, R. T., Fischer-Vize, J. A. (1995). Control of cell fate by Rhee, S. S., and Marsh, J. W. (1994). HIV-1 Nef activity in murine T cells.
J. Immunol. 152, 5128–5134.a deubiquitinating enzyme encoded by the fat facets gene. Science
270, 1828–1831. Rossi, F., Gallina, A., and Milanesi, G. (1996). Nef-CD4 physical interac-
tion sensed with the yeast two-hybrid system. Virology 217, 397–Huang, J., Kwong, J., Sun, E. C., and Liang, T. J. (1996). Proteasome
complex as a potential cellular target of hepatitis B virus X protein. 403.
Rousset, R., Desbois, C., Bantignies, F., and Jalinot, P. (1996). EffectsJ. Virol. 70, 5582–5591.
Jamieson, B. D., Aldrovandi, G. M., Planelles, V., Jowett, J. B., Gao, L., on NF-kB1/p105 processing of the interaction between the HTLV-1
transactivator Tax and the proteasome. Nature 381, 328–331.Bloch, L. M., Chen, I. S., and Zack, J. A. (1994). Requirement of human
immunodeficiency virus type 1 nef for in vivo replication and pathoge- Rivett, A. J., Savory, P. J., and Djaballah, H. (1994). Multicatalytic endo-
peptidase complex: Proteasome. Methods Enzymol. 244, 331–350.nicity. J. Virol. 68, 3478–3485.
Jones, M. H., Furlong, R. A., Burkin, H., Chalmers, J., Brown, G. M., Saksela, K., Cheng, G., and Baltimore, D. (1995). Proline-rich (PxxP)
motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinasesKhwaja, O., and Affara, N. A. (1996). The Drosophila developmental
gene fat facets has a human homolog in Xp11.4 which escapes to and are required for the enhanced growth of Nef/ viruses but not
for down-regulation of CD4. EMBO J. 14, 484–491.X-inactivation and has related sequences on Yq11.2. Hum. Mol.
Genet. 5, 1695–1701. Samuel, K. P., Hodge, D. V., Chen, Y. A., and Papas, T. S. (1991). Nef
proteins of the human immunodeficiency viruses (HIV-1 and HIV-2)Kaminchik, J., Bashan, N., Itach, A., Sarver, N., Gorecki, M., and Panet,
AID VY 8752 / 6a48$$$$84 09-18-97 14:01:46 viras AP: VY
45NEF AND PROTEASOME SUBUNIT HsN3
and simian immunodeficiency virus (SIV) are structurally similar to Smith, B. L., Krushelnycky, B. W., Mochly-Rosen, D., and Berg, P. (1996).
leucine zipper transcriptional activation factors. AIDS Res. Hum. Re- The HIV Nef protein associates with Protein kinase C theta. J. Biol.
troviruses 7, 697–706. Chem. 271, 16753–16757.
Sawai, E. T., Khan, I. H., Montbriand, P. M., Peterlin, B. M., Cheng-Mayer, Swingler, S., Gallay, P., Camaur, D., Song, J., Abo, A., and Trono, D.
C., and Luciw, P. A. (1996). Activation of PAK by HIV and SIV Nef: (1997). The Nef protein of human immunodeficiency virus type 1
importance for AIDS in rhesus macaques. Curr. Biol. 6, 1519–1527. enhances serine phosphorylation of the viral matrix. J. Virol. 71, 4372–
Schmidtke, G., Kraft, R., Kostka, S., Henklein, P., Fro¨mmel, C., Lo¨we, 4377.
J., Huber, R., Kloetzel, P. M., and Schmidt, M. (1996). Analysis of Thomson, S., and RIvett, A. J. (1996). Processing of N3, a mammalian
mammalian 20S proteasome biogenesis: the maturation of b-sub- proteasome beta-type subunit. Biochem. J. 315, 733–738.
units is an ordered two-step mechanism involving autocatalysis.
Trono, D. (1995). HIV accessory proteins: leading roles for the support-
EMBO J. 15, 6887–6898.
ing cast. Cell 82, 189–192.Schwartz, O., Marechal, V., Danos, O., and Heard, J. (1995). Human
Welker, R., Kottler, H., Kalbitzer, H. R., and Kra¨usslich, H. (1996). Humanimmunodeficiency virus type 1 Nef increases the efficiency of reverse
immunodeficiency virus type 1 Nef protein is incorporated into virustranscription in the infected cell. J. Virol. 69, 4053–4059.
particles and specifically cleaved by the viral proteinase. VirologySchwartz, O., Marechal, V., Le Gall, S., Lemonnier, F., and Heard, J.
219, 228–236.(1996). Endocytosis of major histocompatibility complex class I mole-
Wu, J. Y., Zhou, Z. Y., Judd, A., Cartwright, C. A., and Robinson, W. S.cules is induced by the HIV-1 Nef protein. Nat. Med. 2, 338–342.
(1990). The hepatitis B virus-encoded transcriptional trans-activatorSkowronski, J., Parks, D., and Mariani, R. (1993). Altered T cell activation
hbx appears to be a novel protein serine/threonine kinase. Cell 63,and development in transgenic mice expressing the HIV-1 nef gene.
EMBO J. 12, 703–713. 687–695.
AID VY 8752 / 6a48$$$$84 09-18-97 14:01:46 viras AP: VY
